These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7377184)

  • 41. Environmental risk factors for subacute sclerosing panencephalitis (SSPE).
    Zilber N; Kahana E
    Acta Neurol Scand; 1998 Jul; 98(1):49-54. PubMed ID: 9696527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.
    Lucas KM; Sanders RC; Rongap A; Rongap T; Pinai S; Alpers MP
    Epidemiol Infect; 1992 Jun; 108(3):547-53. PubMed ID: 1601084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subacute sclerosing panencephalitis after intrauterine infection.
    Dasopoulou M; Covanis A
    Acta Paediatr; 2004 Sep; 93(9):1251-3. PubMed ID: 15384893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changing character of subacute sclerosing panencephalitis in the United States.
    Dyken PR; Cunningham SC; Ward LC
    Pediatr Neurol; 1989; 5(6):339-41. PubMed ID: 2491742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Data on the incidence of subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1978; 29(3):177-82. PubMed ID: 695322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles.
    Lam T; Ranjan R; Newark K; Surana S; Bhangu N; Lazenbury A; Childs AM; Abbey I; Gibbon F; Thomas G; Singh J; Prabhakar P; Kaminska M; Lascelles K; Hacohen Y; Brown K; Lim M
    Eur J Paediatr Neurol; 2021 Sep; 34():43-49. PubMed ID: 34388650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of measles antigen and immunoglobulin-containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis.
    Esiri MM; Oppenheimer DR; Brownell B; Haire M
    J Neurol Sci; 1982 Jan; 53(1):29-43. PubMed ID: 7035621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subacute sclerosing panencephalitis (SSPE): a report of 16 cases.
    Robbins SJ; Appleton B; Fiumara F; Burke C
    Aust N Z J Med; 1984 Apr; 14(2):126-30. PubMed ID: 6591904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
    Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Subacute sclerosing panencephalitis (SSPE) in Poland 1987-1989. Stage IV of the epidemiological studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1990; 44(4):265-71. PubMed ID: 2100808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SSPE (subacute sclerosing panencephalitis): Is measles vaccination promotive or preventive?
    McDonald R
    Clin Pediatr (Phila); 1977 Feb; 16(2):124-7. PubMed ID: 832436
    [No Abstract]   [Full Text] [Related]  

  • 52. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis.
    Belgamwar RB; Prasad S; Appaya P
    J Indian Med Assoc; 1997 Nov; 95(11):594. PubMed ID: 9567594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiologic features of subacute sclerosing panencephalitis from clinical data of patients receiving a public aid for treatment].
    Nakamura Y; Iinuma K; Oka E; Nihei K
    No To Hattatsu; 2003 Jul; 35(4):316-20. PubMed ID: 12875208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of patient age and year of developing the disease on immunologic response to measles virus in subacute sclerosing panencephalitis (SSPE)].
    Gut W; Kowalewska A
    Med Dosw Mikrobiol; 1993; 45(4):503-10. PubMed ID: 8189831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Subacute sclerosing panencephalitis cases diagnosed by increased CSF/serum measles antibody indices].
    Samlıoğlu P; Unalp A; Gökçay A; Altuğlu I; Oztürk A; Zeytinoğlu A
    Mikrobiyol Bul; 2012 Oct; 46(4):716-8. PubMed ID: 23188587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subacute sclerosing panencephalitis in Delhi.
    Khare S; Kumari S; Verghese T
    J Trop Pediatr; 1994 Dec; 40(6):326-8. PubMed ID: 7853435
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of subacute sclerosing panencephalitis.
    Modlin JF; Halsey NA; Eddins DL; Conrad JL; Jabbour JT; Chien L; Robinson H
    J Pediatr; 1979 Feb; 94(2):231-6. PubMed ID: 762612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subacute sclerosing panencephalitis--a Pakistan perspective.
    Tariq WUZ ; Waqar T; Ghani E
    Trop Doct; 2001 Apr; 31(2):110. PubMed ID: 11321259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated ratio of late measles among subacute sclerosing panencephalitis patients in Karachi, Pakistan.
    Takasu T; Kondo K; Ahmed A; Yoshikawa Y; Yamanouchi K; Tsuchiya M; Murakami N; Ueda S
    Neuroepidemiology; 1992; 11(4-6):282-7. PubMed ID: 1291892
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
    Naruszewicz-Lesiuk D; Iwińska-Buksowicz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Neurol Neurochir Pol; 2000; 34(5):877-85. PubMed ID: 11253477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.